A comparative study of Korean with Caucasian breast cancer reveals frequency of methylation in multiple genes correlates with breast cancer in young, ER, PR-negative breast cancer in Korean women

Cancer Biology and Therapy

Volumn 6, Issue 7, 2007, Pages 1114-1120

  Ji, Shin Lee ^a,b   Lo, Pang Kuo ^a   Fackler, Mary Jo ^a   Argani, Pedram ^a   Zhang, Zhe ^a   Garrett Mayer, Elizabeth ^a   Sukumar, Saraswati ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Chonnam National University Medical School   (South Korea)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Age; Breast; Cancer; ER; Ethnic group; Methylation; PCR

Indexed keywords

DNA; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CAUCASIAN; CDH1 GENE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYCLIN D2 GENE; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; ETHNIC GROUP; FEMALE; GENE; GROUPS BY AGE; GSTP1 GENE; HIN 1 GENE; HUMAN; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; METHYLATION; POLYMERASE CHAIN REACTION; PREVALENCE; PROMOTER REGION; RAR BETA GENE; RASSF1A GENE; TWIST GENE; UNITED STATES;

EID: 42449141512     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.6.7.4331     Document Type: Article

References (32)

1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin 2000; 50:7-33.
2. Hunter CP. Epidemiology, stage at diagnosis, and tumor biology of breast carcinoma in multiracial and multiethnic populations. Cancer 2000; 88:1193-202.
3. Ahn SH. Clinical characteristics of breast cancer patients in Korea in 2000. Arch Surg 2004; 139:27-30.
4. MacMahon B. Epidemiology and the causes of breast cancer. Int J Cancer 2006; 118:2373-8.
5. Widschwendter M, Jones PA. DNA methylation and breast carcinogenesis. Oncogene 2002; 21:5462-82.
6. Chlebowski RT, Chen Z, Anderson GL, Rohan T, Aragaki A, Lane D, Dolan NC, Paskett ED, McTiernan A, Hubbell FA, Adams-Campbell LL, Prentice R. Ethnicity and breast cancer: Factors influencing differences in incidence and outcome. J Natl Cancer Inst 2005; 97:439-48.
7. Beckmann MW, Niederacher D, Schnurch HG, Gusterson BA, Bender HG. Multistep carcinogenesis of breast cancer and tumour heterogeneity. J Mol Med 1997; 75:429-39.
8. Ameyaw MM, Tayeb M, Thornton N, Folayan G, Tariq M, Mobarek A, Evans DA, Ofori-Adjei D, McLead HL. Ethnic variation in the HER-2 codon 655 genetic polymorphism previously associated with breast cancer. J Hum Genet 2002; 47:172-5.
9. Choi DH, Shin DB, Lee MH, Lee DW, Dhandapani D, Carter D, King BL, Haffty BG. A comparison of five immunohistochemical biomarkers and HER-2/neu gene amplification by fluorescence in situ hybridization in white and Korean patients with early-onset breast carcinoma. Cancer 2003; 98:1587-95.
10. Choi DH, Lee MH, Bale AE, Carter D, Haffty BG. Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients. J Clin Oncol 2004; 22:1638-45.
11. Packeisen J, Nakachi K, Boecker W, Brandt B, Buerger H. Cytogenetic differences in breast cancer samples between German and Japanese patients. J Clin Pathol 2005; 58:1101-3.
12. Baylin SB. DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol 2005; Suppl 1:4-11.
13. Mehrotra J, Ganpat MM, Kanaan Y, Fackler MJ, McVeigh M, Lahti-Domenici J, Polyak K, Argani P, Naab T, Garrett E, Parmigiani G, Broome C, Sukumar S. Estrogen receptor/progesterone receptor-negative breast cancers of young African-American women have a higher frequency of methylation of multiple genes than those of Caucasian women. Clin Cancer Res 2004; 10:2052-7.
14. Bae YK, Brown A, Garrett E, Bornman D, Fackler MJ, Sukumar S, Herman JG, Gabrielson E. Hypermethylation in histologically distinct classes of breast cancer. Clin Cancer Res 2004; 10:5998-6005.
15. Graff JR, Herman JG, Lapidus RG, Chopra H, Xu R, Jarrard DF, Isaacs WB, Pitha PM, Davidson NE, Baylin SB. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res 1995; 55:5195-9.
16. Fackler MJ, McVeigh M, Evron E, Garrett E, Mehrotra J, Polyak K, Sukumar S, Argani P. DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma. Int J Cancer 2003; 107:970-5.
17. Krassenstein R, Sauter E, Dulaimi E, Battagli C, Ehya H, Klein-Szanto A, Cairns P. Detection of breast cancer in nipple aspirate fluid by CpG island hypermethylation. Clin Cancer Res 2004; 10:28-32.
18. Association of directors of anatomic and surgical pathology. Recommendations for the reporting of breast carcinoma. Hum Pathol 1996; 27:220-4.
19. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M. Breast. Cancer Staging Manual. 6th eds. New York: Springer-Verlag, 2002:223-40.
20. Evron E, Umbricht CB, Korz D, Raman V, Loeb DM, Niranjan B, Buluwela L, Weitzman SA, Marks J, Sukumar S. Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation. Cancer Res 2001; 61:2782-7.
21. Fackler MJ, McVeigh M, Mehrotra J, Blum MA, Lange J, Lapides A, Garrett E, Argani P, Sukumar S. Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer. Cancer Res 2004; 64:4442-52.
22. Fackler MJ, Malone K, Zhang Z, Schilling E, Garrett-Mayer E, Swift-Scanlan T, Lange J, Nayar R, Davidson NE, Khan SA, Sukumar S. Quantitative multiplex methylation-specific PCR analysis doubles detection of tumor cells in breast ductal fluid. Clin Cancer Res 2006; 12:3306-10.
23. Palmisano WA, Divine KK, Saccomanno G, Gilliland FD, Baylin SB, Herman JG, Belinsky SA. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 2000; 60:5954-8.
24. House MG, Herman JG, Guo MZ, Hooker CM, Schulick RD, Lillemoe KD, Cameron JL, Hruban RH, Maitra A, Yeo CJ. Aberrant hypermethylation of tumor suppressor genes in pancreatic endocrine neoplasms. Ann Surg 2003; 238:423-31.
25. Huang J, Tan PH, Thiyagarajan J, Bay BH. Prognostic significance of glutathione S-transferase-pi in invasive breast cancer. Mod Pathol 2003; 16:558-65.
26. Newton MA, Kendziorski CM. Parametric empirical Bayes methods for microarrays. In: Parmigiani G, Garrett ES, Irizarry RA, Zeger SL, eds. The analysis of gene expression data: Methods and software. New York: Springer, 2003:254-69.
27. Gilks WR, Thomas A, Spiegelhalter DJ. A language and program for complex Bayesian modeling. Statistician 1994; 43:169-78.
28. Woodson K, Hayes R, Wideroff L, Villaruz L, Tangrea J. Hypermethylation of GSTP1, CD44, and E-cadherin genes in prostate cancer among US Blacks and Whites. Prostate 2003; 55:199-205.
29. House MG, Wistuba II, Argani P, Guo M, Schulick RD, Hruban RH, Herman JG, Maitra A. Progression of gene hypermethylation in gallstone disease leading to gallbladder cancer. Ann Surg Oncol 2003; 10:882-9.
30. Li SY, Rong M, Iacopetta B. DNA hypermethylation in breast cancer and its association with clinicopathological features. Cancer Lett 2006; 237:272-80.
31. Toyota M, Issa JP. CpG island methylator phenotypes in aging and cancer. Semin Cancer Biol 1999; 9:349-57.
32. Widschwendter M, Jones PA. The potential prognostic, predictive, and therapeutic values of DNA methylation in cancer. Clin Cancer Res 2002; 8:17-21.